What is it about?
This paper analyses the effectiveness of a new antifungal treatment for valley fever. Both species of fungi that cause the disease were assayed. This drug works as well or better than the standard antifungal Fluconazole.
Featured Image
Why is it important?
Fungal infections like valley fever are notoriously hard to treat in certain patients, and in some cases, patients must take antifungals for the rest of their life. The need to have new and better treatments is clear.
Perspectives
Our group completed the assays to determine species identification and verify all samples tested were indeed either Coccidioides posadasii or C. immtitis.
Dr Bridget Marie Barker
Translational Genomics Research Institute
Read the Original
This page is a summary of: Evaluation of VT-1161 for Treatment of Coccidioidomycosis in Murine Infection Models, Antimicrobial Agents and Chemotherapy, September 2015, ASM Journals,
DOI: 10.1128/aac.00593-15.
You can read the full text:
Contributors
The following have contributed to this page
